Skip to main content
Equibles

Christopher I. Wright, M.D., Ph.D.

Board Member

Alkermes plc. (ALKS)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Christopher I. Wright, M.D., Ph.D.

Christopher I. Wright, M.D., Ph.D. is recorded as Board Member at Alkermes plc. (ALKS). Alkermes plc. reported in an 8-K filed May 31, 2024 that Christopher I. Wright, M.D., Ph.D. was appointed director, effective May 31, 2024. Alkermes plc. reported in an 8-K filed July 7, 2022 that Christopher I. Wright, M.D., Ph.D. was appointed Class II director, effective July 7, 2022.

“By separate resolutions, shareholders elected the following directors, each to serve for a one-year term expiring at the Company’s 2025 annual general meeting of shareholders, or until their respective successor is elected and shall qualify, with the votes cast as follows:”
Alkermes plc. Form 8-K, filed May 31, 2024 · Read the filing
“Shareholders elected Christopher I. Wright, M.D., Ph.D. as a Class II director to serve for a one-year term expiring at the 2023 Annual Meeting or until his respective successor is elected and shall qualify, with the votes cast as follows: 143,714,856 votes for; 2,304,330 votes against; 50,308 votes abstaining; and 7,473,765 broker non-votes.”
Alkermes plc. Form 8-K, filed July 7, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Alkermes plc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.